Focal scleroderma and severe cardiomyopathy. Patient report and brief review

E C Moore1, F Cohen, Z Farooki

  • 1Division of Clinical Immunology, Children's Hospital of Michigan, Detroit 48201.

Insights

This study reports the first case of localized scleroderma with severe heart failure in an infant. Prednisone therapy successfully treated both cardiac and serological abnormalities, highlighting the potential for systemic involvement.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Cardiology

Background:

  • Localized scleroderma is a connective tissue disease typically affecting the skin.
  • Cardiac involvement is rare in localized scleroderma, more commonly seen in systemic sclerosis.
  • Infantile cardiomyopathy presents a significant diagnostic and therapeutic challenge.

Observation:

  • A 21-month-old infant presented with simultaneous localized scleroderma and severe cardiomyopathy.
  • The infant exhibited cardiac dysfunction and elevated inflammatory markers, including rheumatoid factor, IgM, IgG, and erythrocyte sedimentation rate.
  • Skin manifestations of scleroderma were also present.

Findings:

  • Prednisone therapy led to the normalization of cardiac function and serological abnormalities.
  • Significant, though incomplete, resolution of skin lesions was observed concurrently.
  • This case represents the first documented instance of clinically significant cardiac involvement in localized scleroderma.

Implications:

  • Localized scleroderma may be associated with serious internal organ involvement, particularly cardiac disease.
  • Early recognition and treatment of cardiac complications are crucial in pediatric scleroderma cases.
  • This case underscores the importance of considering systemic manifestations in patients with focal scleroderma.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...